Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates docetaxel for recurrent or refractory germ cell cancers, including extragonadal germ cell tumors, ovarian cancer, and testicu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Ovarian Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer | Phase 2 | Status: COMPLETED